FDA Adverse Event Other Summary report: N

FIXODENT DENTURE ADHESIVE, FORM/VERSION UNK (CALCIUM ZINC GANTREZ SALT 33-59% CE

MDR report key: 1651939 · Received April 5, 2010

Report

Report Number
1530449-2010-00012
Event Type
Other
Date Received
April 5, 2010
Date of Event
July 15, 2005
Report Date
November 16, 2009
Manufacturer
PROCTER & GAMBLE CO
Product Code
KOO
PMA / PMN Number
K945200
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

LOT NUMBER OF PRODUCT WAS NOT PROVIDED BY THE REPORTER; THEREFORE, UNABLE TO PROCEED WITH BATCH RETAIN TESTING OR PRODUCT INVESTIGATION. ADD'L INFO - (US) OTC DEVICE.

Description of Event or Problem · 1

LEUKEMIA [LEUKEMIA]; PASSING OUT [LOSS OF CONSCIOUSNESS]; VOMITING [VOMITING]; WEAKNESS [ASTHENIA]; INABILITY TO WALK [ABASIA]; MDS SYNDROME [MYELODYSPLASTIC SYNDROME]; FAINTING [SYNCOPE]; INABILITY TO STAND [DYSSTASIA]; HIGH ZINC [BLOOD COPPER DECREASED]; PERIPHERAL NEUROPATHY [NEUROPATHY PERIPHERAL]. CASE DESCRIPTION: A REGULATORY AUTHORITY REP REPORTED THAT THEY WERE NOTIFIED THAT AN ADULT CONSUMER, GENDER AND AGE UNSPECIFIED, USED FIXODENT DENTURE ADHESIVE. FORM/VERSION UNK, POLIGRIP DENTURE ADHESIVE, OR SEA BOND DENTURE ADHESIVE DAILY (B)(6) 1997 THROUGH (B)(6) 2009 TO HOLD LOOSE DENTURES AND REPORTED THE FOLLOWING: LEUKEMIA, MYELODYSPLASTIC SYNDROME, PERIPHERAL NEUROPATHY, PASSING OUT, FAINTING, VOMITING, WEAKNESS, INABILITY TO WALK, INABILITY TO STAND, HIGH ZINC, AND ZERO COPPER LEVEL. HEALTH CARE PROFESSIONALS WERE VISITED. TREATMENT: BLOOD TRANSFUSIONS BI-WEEKLY, BLOOD BUILDING INJECTIONS TWICE WEEKLY. VIDAZA CHEMOTHERAPY, AND AGGRESSIVE VITAMIN AND MINERAL INTAKE. THE CASE OUTCOME WAS IMPROVED. NO FURTHER INFO WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FIXODENT DENTURE ADHESIVE, FORM/VERSION UNK (CALCIUM ZINC GANTREZ SALT 33-59% CE DENTURE ADHESIVE KOO PROCTER & GAMBLE CO

Patients

Seq Age Sex Outcome Treatment
1 Other| R